View Cart (0 items)

Pharmaceutical

Sanofi-Aventis to Cut 1,700 US Jobs

October 11, 2010
The BBC reports, French pharmaceutical giant Sanofi-Aventis has announced it will shed 1,700 jobs from its U.S. workforce. The move is part of a restructuring process that will allow
Read More

Sanofi Launches Hostile Bid for Genzyme

October 4, 2010
Sanofi-Aventis said that it has launched a hostile $18.5 billion offer for Genzyme Corp. after the U.S. company previously rejected an approach at the same price, reports MarketWatch. The offer
Read More

Crown Holdings to Build Three Beverage Can Plants in China

September 27, 2010
Crown Holdings Inc. will build three new beverage can plants in China in order to keep up with increased demand, the packaging products supplier said, reports the Associated Press. The
Read More

Hospira Neutropenia Drug Approved in Australia

September 27, 2010
The Associated Press Reports, Hospira has received approval to sell a generic version of the biotech drug Neupogen in Australia. Hospira said its drug, called Nivestim, was approved to prevent
Read More

Genzyme Says Synvisc Approved in Japan

September 20, 2010
The Associated Press reports, Genzyme Corp. said its drug Synvisc, which treats osteoarthritis of the knee, has been approved in Japan. Genzyme said it received marketing approval from the Ministry
Read More

Genzyme Selling Genetic Lab Unit for $925 Million

September 13, 2010
U.S. biotechnology company Genzyme has agreed to sell its genetic testing business to Laboratory Corp of America Holdings for $925 million in cash, reports Reuters. Genzyme said its plan
Read More

Genzyme Board Rejects Sanofi Bid

August 30, 2010
The board of directors at U.S. biotechnology firm Genzyme has unanimously rejected an 18.5-billion-dollar takeover offer from French pharmaceutical giant Sanofi-Aventis, reports the Associated Foreign Press. A letter to Sanofi
Read More

Swiss Drug Maker Roche Buying US Scanning Company

August 23, 2010
According to the Associated Press, Swiss pharmaceutical company Roche Group is buying California-based medical scanning company BioImagene Inc. for $100 million. Roche made the announcement and says it expects to
Read More

Merck Receives US Inquiries Over Practices in Foreign Countries

August 9, 2010
U.S. drug maker Merck & Co. said it has received letters from the federal government seeking information about its activities in foreign countries, in connection with a U.S. anti-foreign bribery
Read More

Charles River Withdraws Offer for Chinese Company

August 2, 2010
According to the Boston Herald, Charles River Laboratories has withdrew a $1.6 billion bid for WuXi PharmaTech, citing investor opposition to what would have been the largest foreign takeover of
Read More